Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Digital versus speculum insertion of Foley catheter for cervical ripening: A systematic review and meta-analysis of randomized controlled trials.

Medicine·2026

Same author

Crystallographic analysis of a putative FAD-dependent oxidoreductase identifies a potentially misfolded apo structure in a soluble monomeric state.

Journal of structural biology·2026

Same author

Discovery of a triple-site inhibitor targeting bacterial methionyl-tRNA synthetase through combined drug repurposing screening and generative AI-assisted optimization.

Nucleic acids research·2026

Same author

Substrate l-isoleucine facilitates the hyper inhibition of reveromycin A on human cytoplasmic isoleucyl-tRNA synthetase.

Archives of biochemistry and biophysics·2026

Same author

The Structure of Carboxyl Methyltransferase Provides Insights Into the Substrate Specificity and Divergent Evolution of Iridoid.

Plant biotechnology journal·2026

Same author

UMP functions as an endogenous regulator of NR4A1 to control gastric cancer progression.

Molecular cell·2025

Same journal

High-performance broadband SiC nanoparticles/porous silicon photodetector prepared by laser ablation in liquid.

RSC advances·2026

Same journal

Conjugated biopolymer assisted separation of nanoplastics from aqueous systems: a step towards sustainability.

RSC advances·2026

Same journal

Recent progress in the direct monofluoromethylation of C-H bonds.

RSC advances·2026

Same journal

Recent advances in azo-based probes for analyte sensing: molecular nanoarchitectonics and advanced applications.

RSC advances·2026

Same journal

Synthesis and characterization of a glutathione-responsive NIR-II fluorescent probe with Fenton-like reaction activity.

RSC advances·2026

Same journal

Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole-<i>N</i>-phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors.

RSC advances·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 24, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

LSA: a local-weighted structural alignment tool for pharmaceutical virtual screening.

Xiuming Li¹, Xin Yan¹, Yuedong Yang²

¹Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University 132 East Circle at University City Guangzhou 510006 China junxu@biochemomes.com.

|May 6, 2022

Summary

This summary is machine-generated.

A new tool, local-weighted structural alignment (LSA), accurately measures molecular similarity by combining overall shape and local substructure analysis for drug discovery. This method improves virtual screening performance over traditional approaches.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

A Protocol for Computer-Based Protein Structure and Function Prediction

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

Related Experiment Videos

Last Updated: Sep 24, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

A Protocol for Computer-Based Protein Structure and Function Prediction

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

Area of Science:

Computational chemistry
Cheminformatics
Drug discovery

Background:

Molecular similarity is crucial for identifying new functional molecules, but minor structural changes can significantly alter activity.
Existing methods for measuring molecular similarity are broadly categorized into overall 3D shape-based and local substructure-based approaches.
Effective molecular similarity assessment requires considering contributions from both overall shape and local substructure.

Purpose of the Study:

To introduce a novel tool, local-weighted structural alignment (LSA), for pharmaceutical virtual screening.
To develop a method that computes molecular similarity by integrating overall structural similarity and local substructure match.
To validate the performance of LSA against conventional methods in identifying active molecules.

Main Methods:

LSA involves three key steps: mapping common substructures, superimposing 3D molecular structures with a substructure focus, and calculating a similarity score.
The tool considers contributions from both overall molecular shape and local substructure details.
Implementation is in C++ for cross-platform compatibility (Linux and Windows).

Main Results:

LSA demonstrated strong performance in virtual screening, validated on 102 compound libraries from the DUD-E collection.
Achieved an average Area Under the Curve (AUC) of 0.82.
Obtained an average Enrichment Factor at 1% (EF1%) of 27.0, outperforming conventional methods.

Conclusions:

LSA provides a more accurate assessment of molecular similarity compared to traditional methods.
The tool enhances the efficiency and effectiveness of pharmaceutical virtual screening.
LSA's ability to integrate global and local structural features offers a significant advancement in drug discovery pipelines.